Covid-19 put many businesses on hold, but not biotech. This sector is growing at record speeds, and only a small portion of the capital deals are related to the pandemic.
Seemingly in response to global uncertainty over the coronavirus outbreak, the stock markets have plunged, numerous conferences are being canceled and biopharma companies are taking action.
U.S. President Donald Trump will meet with Treasury Secretary Steven Mnuchin and other economic officials to weigh possible actions to stem the fallout from a widening coronavirus outbreak, an administration official told Reuters.
